On June 6th Business Sweden and one of Europe’s largest life science clusters, One Nucleus, arrange a morning seminar at the BIO International Convention in San Francisco.
The first part of the seminar is mainly a discussion regarding collaboration models between tech companies and large pharma companies. How will they collaborate, compete and will they join forces in this time of digitalization and new technology when business models has to be changed. Experts from Johnson & Johnson and Philips are included as speakers.
The other part of the seminar is a presentation of Swedish strengths within life science and what Sweden can offer international players in the form of collaboration possibilities, companies to invest in etc. Anders Lönnberg, the Swedish government’s national life science coordinator, will participate.
“My mission is to in different ways gather Swedish life science players to consensus, common priorities and concerete efforts for a better quality and equality in healthcare, not least by increasing the development of digitalization within healthcare,” says Anders Lönnberg. “In addition my work is to make sure that research, development and innovation is a natural part of healthcare and to stimulate conditions where innovations may be turned into new products and services which will lead to new export incomes.”